Amneal Pharmaceuticals Inc

AMRX

$7.45

Closing

▲2.90%

1D

▲22.73%

YTD

AMRX

BBG00462PGH9

Market cap

$2.30B

52 week high

$7.74

52 week low

$2.99

Volume

295,344

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$2.30B

Analysts' Rating

BUY

Price Target (Mean)

8.25

Total Analysts

5

P/E

Operating Margin

-1.63%

Beta

1.23

Revenue Growth (Annual)

18.23%

52 week high

$7.74

52 week low

$2.99

Div. Yield

%

EPS Annual Growth

-25.00

Company Profile

Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company’s Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.